Transcatheter closure of residual atrial septal defect following cardiac transplantation.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 8448802)

Published in Cathet Cardiovasc Diagn on February 01, 1993

Authors

M P O'Laughlin1, J T Bricker, C E Mullins, A K Cabalka, B D Gelb, J A Towbin

Author Affiliations

1: Lillie Frank Abercrombie Section of Cardiology, Texas Children's Hospital, Waco.

Articles by these authors

SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell (1995) 7.73

Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation (2000) 7.50

Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47

Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature (1998) 7.26

Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet (2001) 6.96

Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation (2000) 5.09

Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res (1999) 4.57

Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation (1995) 4.48

Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA Occluder System. Circulation (1987) 4.46

Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation (2000) 3.99

ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation (1995) 3.79

Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med (1998) 3.41

Use of endovascular stents in congenital heart disease. Circulation (1991) 3.40

ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol (1997) 3.14

Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J (2002) 3.01

Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation (2000) 2.95

Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA (2001) 2.89

The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol (1999) 2.56

Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation (1998) 2.53

Implantation and intermediate-term follow-up of stents in congenital heart disease. Circulation (1993) 2.53

Long-term follow-up of the STARFlex device for closure of secundum atrial septal defect. Catheter Cardiovasc Interv (2009) 2.52

Scenarios: a planning tool for health care organizations. Hosp Health Serv Adm (1991) 2.41

Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation (2001) 2.24

Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group. Circulation (1998) 2.23

Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome. Eur Heart J (2002) 2.17

Human herpes virus 6 in archival cardiac tissues from children with idiopathic dilated cardiomyopathy or congenital heart disease. J Clin Pathol (2008) 2.07

Cardiac dysfunction and mortality in HIV-infected children: The Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group. Circulation (2000) 2.04

Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest (2000) 1.91

KCNE1 mutations cause jervell and Lange-Nielsen syndrome. Nat Genet (1997) 1.90

Dysrhythmias after Mustard's operation for transposition of the treat arteries. Am J Cardiol (1972) 1.89

Experience with 205 procedures of transcatheter closure of ductus arteriosus in 182 patients, with special reference to residual shunts and long-term follow-up. J Thorac Cardiovasc Surg (1992) 1.88

Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med (2000) 1.87

Repeat dilation of intravascular stents in congenital heart defects. Circulation (1995) 1.85

ACC/AHA guidelines for exercise testing: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). Circulation (1997) 1.83

Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med (2001) 1.78

Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation (1997) 1.76

CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia. Hum Mol Genet (1999) 1.72

Detection of microorganisms in the tracheal aspirates of preterm infants by polymerase chain reaction: association of adenovirus infection with bronchopulmonary dysplasia. Pediatr Res (2000) 1.72

Subacute postictal aggression. Neurology (1998) 1.68

Cardiac complications in children with human immunodeficiency virus infection. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group, National Heart, Lung, and Blood Institute. Pediatrics (1999) 1.68

Failure to detect connexin43 mutations in 38 cases of sporadic and familial heterotaxy. Circulation (1996) 1.65

Design and implementation of the North American Pediatric Cardiomyopathy Registry. Am Heart J (2000) 1.65

Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene. Am J Med Genet (1996) 1.65

Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat Genet (2000) 1.62

Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome. Nat Genet (1999) 1.62

Reliability of multicenter pediatric echocardiographic measurements of left ventricular structure and function: the prospective P(2)C(2) HIV study. Circulation (2001) 1.61

Noonan syndrome: clinical aspects and molecular pathogenesis. Mol Syndromol (2010) 1.60

Sizing of atrial septal defects to predict successful closure with transcatheter cardioSEAL device. Tex Heart Inst J (2001) 1.57

Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet (1994) 1.55

Visualization of the pulmonary arteries in pseudotruncus by pulmonary vein wedge angiography. Circulation (1978) 1.55

Exercise capacity and incidence of myocardial perfusion defects after Kawasaki disease in children and adolescents. J Am Coll Cardiol (1995) 1.55

New mutations in the KVLQT1 potassium channel that cause long-QT syndrome. Circulation (1998) 1.53

Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology (1993) 1.52

Transcatheter occlusion of ventricular septal defect. Cathet Cardiovasc Diagn (1989) 1.51

Intravascular stents in congenital heart disease: short- and long-term results from a large single-center experience. J Am Coll Cardiol (1998) 1.48

Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. Circulation (1999) 1.44

The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz (2000) 1.42

Severe cardiopathy in branching enzyme deficiency. J Pediatr (1987) 1.41

Quantitative echocardiographic analysis of the aortic arch predicts outcome of balloon angioplasty of native coarctation of the aorta. Circulation (1996) 1.40

Closed head injury resulting in paradoxical improvement of a seizure disorder. Seizure (2000) 1.39

Sudden death after repair of tetralogy of Fallot. Electrocardiographic and electrophysiologic abnormalities. Circulation (1977) 1.38

Management of symptomatic infants with anomalous origin of the left coronary artery from the pulmonary artery. Am J Cardiol (1981) 1.36

Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties. J Biol Chem (2001) 1.36

Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation (2000) 1.36

Variation in the phenotypic expression of beta-glucuronidase deficiency. J Pediatr (1975) 1.33

Alterations in cardiac and pulmonary function in pediatric rapid human immunodeficiency virus type 1 disease progressors. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Study Group. Pediatrics (2000) 1.31

Linkage of pycnodysostosis to chromosome 1q21 by homozygosity mapping. Nat Genet (1995) 1.30

Genetic and molecular basis of cardiac arrhythmias; impact on clinical management. Study group on molecular basis of arrhythmias of the working group on arrhythmias of the european society of cardiology. Eur Heart J (1999) 1.29

Outcome of pregnancy following intervention for coarctation of the aorta. Am J Cardiol (1998) 1.28

Familial hypertrophic cardiomyopathy in maine coon cats: an animal model of human disease. Circulation (1999) 1.28

Left-right axis malformations associated with mutations in ACVR2B, the gene for human activin receptor type IIB. Am J Med Genet (1999) 1.27

Assessing the importance of genotype x environment interaction for root traits in rice using a mapping population II: conventional QTL analysis. Theor Appl Genet (2006) 1.27

Catheter closure of congenital cardiac defects. Cardiol Clin (1989) 1.26

Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol (1999) 1.25

Double balloon technique for dilation of valvular or vessel stenosis in congenital and acquired heart disease. J Am Coll Cardiol (1987) 1.24

Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis. J Clin Invest (1999) 1.23

Congenital stenosis of individual pulmonary veins: clinical spectrum and unsuccessful treatment by transvenous balloon dilation. Am J Cardiol (1982) 1.20

Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation. Am J Hum Genet (2001) 1.20

Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med (1998) 1.20

Natural history of growth of secundum atrial septal defects and implications for transcatheter closure. Heart (2002) 1.19

Genetics of peanut allergy: a twin study. J Allergy Clin Immunol (2000) 1.19

Re-expansion of balloon-expandable stents after growth. J Am Coll Cardiol (1993) 1.19

Viral infection of the myocardium in endocardial fibroelastosis. Molecular evidence for the role of mumps virus as an etiologic agent. Circulation (1997) 1.17

Guidelines for exercise testing in the pediatric age group. From the Committee on Atherosclerosis and Hypertension in Children, Council on Cardiovascular Disease in the Young, the American Heart Association. Circulation (1994) 1.15

Natural hemodynamic history of congenital aortic stenosis in childhood. Am J Cardiol (1972) 1.14

Redilation of endovascular stents in congenital heart disease: factors implicated in the development of restenosis and neointimal proliferation. J Am Coll Cardiol (2001) 1.13

Phenotypic and genotypic characterisation of Noonan-like/multiple giant cell lesion syndrome. J Med Genet (2005) 1.13

Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol (2001) 1.12

Coronary artery fistula. Management and intermediate-term outcome after transcatheter coil occlusion. Tex Heart Inst J (2001) 1.12

18-year experience with transseptal procedures through baffles, conduits, and other intra-atrial patches. Catheter Cardiovasc Interv (2000) 1.12

Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation (1999) 1.11

Benign extra-axial collections of infancy. Pediatr Neurosci (1987) 1.11

Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part III. Circulation (1999) 1.11

Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation (1997) 1.10

Cardiac transplantation in an 8-month-old female infant with subendocardial fibroelastosis. JAMA (1986) 1.10

Electrocardiographic criteria for diagnosis of acute myocardial infarction in childhood. Am J Cardiol (1992) 1.09

Use of intravascular stents in systemic venous and systemic venous baffle obstructions. Short-term follow-up results. Circulation (1995) 1.09

Transseptal left heart catheterization: experience with a new technique in 520 pediatric and adult patients. Pediatr Cardiol (1984) 1.09